OCSTA Welcomes School Facilities Improvement Funding
TORONTO, Oct. 28, 2020 /CNW/ - "We welcome and very much appreciate the additional funding announced today for improvements to school facilities throughout Ontario. This significant investment will support Catholic Boards in their commitment to provide the safest, highest quality learning environments possible for their students and staff," said Patrick Daly, President of the Ontario Catholic School Trustees' Association.
The $1.05 billion dollar federal/provincial combined funding under the COVID-19 Infrastructure Stream, includes a maximum of $700 million for education-related projects to be nominated and administered by the Ministry of Education, in consultation with school boards.
"We look forward to receiving further details of the funding allocations and assisting our member boards in proceeding with projects as soon as possible," added Mr. Daly.
The Ontario Catholic School Trustees' Association is the provincial voice for publicly funded Catholic education. Founded in 1930, OCSTA represents the interests of Catholic school boards that collectively educates approximately 600,000 students in Ontario, from Junior Kindergarten to Grade 12.
SOURCE Ontario Catholic School Trustees' Association
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
